The clinical assessment and treatment of pain are fundamental pillars of healthcare, yet evidence reveals a systemic failure to provide equitable analgesia across different ethnic groups. This “ethnicity pain gap” manifests as a recurring pattern where patients from minority backgrounds are less likely to have their pain recognised, believed, or adequately treated. These disparities are not isolated incidents but persist across the entire human lifespan, from paediatric emergency care to the final stages of palliative treatment.
Systemic Bias in Paediatric Pain Assessment
Racial disparities in pain management begin in childhood, often rooted in the subconscious biases of those interpreting physical distress. Research indicates that the perceived intensity of pain varies based on the ethnicity of the patient, which directly influences the clinical decision to provide treatment and the willingness of clinicians to escalate analgesia.
A study involving computer-generated images of children’s faces demonstrated that pain was less readily perceived on the faces of black boys compared with white children. This perceptual gap meant that observers required a more intense expression of distress from black children before acknowledging that pain was present. Crucially, those who failed to perceive pain in black children were also less likely to recommend appropriate medical intervention, reinforcing a cycle in which suffering goes both unseen and untreated.
| Condition/Setting | Observed Disparity in Paediatric Care |
|---|---|
| Long-bone Fractures | Minority children more likely to receive non-opioids (paracetamol/ibuprofen) but less likely to receive opioids for comparable injuries and reported pain scores. |
| Appendicitis | Black children 80% less likely to receive opioids for severe pain than white counterparts presenting with similar clinical findings. |
| Post-Surgical Recovery | Black children at four times greater risk of complications, including severe uncontrolled pain, following surgery. |
The failure to provide optimal pain reduction in emergency settings leads to poorer discharge outcomes and avoidable returns to hospital. Regarding fractures, Dr Goyal noted: “When looking at optimal pain reduction, minority children were more likely to be discharged home in significant pain compared with their white counterparts. We found that even after we adjusted for injury severity and pain intensity, minority children were less likely to receive opioids for the treatment of their fracture pain.” For health systems that publicly commit to equality of access, this represents not just a clinical gap but a breach of their own stated standards of care.
Obstetric Care and Racial Stereotyping
In maternity services, the pain gap is exacerbated by deeply ingrained sociocultural stereotypes that influence how clinicians respond to the distress of pregnant women. These biases not only affect comfort in labour but are linked to critical safety failings, delayed escalation of care and higher mortality rates among minority ethnic women.
- Safety and Mortality: Black women are nearly twice as likely to have their births investigated for safety failings and remain almost three times more likely to die during childbirth than white women in the same health systems.
- Stereotyped Perceptions: Reports indicate Asian women are sometimes stereotyped as “princesses”, implying they are overly demanding, while black women are viewed as having “tough skin” and a higher natural tolerance for pain, a notion that lacks scientific basis and reflects wider racialised narratives about physical endurance.
- Treatment Denial: Survey data shows 23% of black women did not receive requested pain relief during childbirth, with 40% of those women receiving no explanation for the denial, despite national patient charters that emphasise informed consent and shared decision-making.
These perceptions create a dangerous environment where clinical needs are dismissed based on racial assumptions rather than assessed against objective clinical criteria. One woman described the experience: “I feel like, for us black ladies, they feel like we can handle the pain, even when we are complaining we are in pain.” Others reported that attempting to advocate for their own care led to being labeled as “the angry or aggressive black woman,” a stereotype that further degraded the quality of care received and discouraged them from speaking up. One patient recalled: “I was begging for help … I was made to feel like I was that aggressive, angry black woman. But that isn’t me.”
For policymakers and regulators, these testimonies raise questions about whether existing complaints mechanisms, maternity safety reviews and professional training requirements are adequately capturing and correcting race-based patterns of dismissal.
Acute Care, Guidelines and Regulatory Compliance
The disparity in pain management is particularly acute in emergency departments, where rapid decision-making often allows implicit bias to supersede clinical guidelines and triage protocols. For non-definitive conditions such as abdominal or back pain, black patients in the US have been found to be half as likely to be prescribed opioid medications as white patients, even when presenting with similar symptoms and levels of reported pain.
Prof Keisha Ray observed: “This study unfortunately tells us what we already know: black patients are improperly treated for pain and that is mostly because of their skin colour.” Her comments speak directly to the limits of purely technical fixes in systems where bias is embedded in everyday judgment calls.
This failure is most evident in the management of sickle cell disease, a condition predominantly affecting people of African descent and long recognised in national policy as a priority for rapid analgesia. Despite the existence of national care standards such as the NICE guideline on sickle cell disease in crisis, there is a routine failure to comply with these protocols in emergency settings, including recommended timeframes for first-line opioid administration. Patients often report having to “battle” for effective analgesia during a sickle cell crisis, suggesting that institutional adherence to evidence-based pain protocols is inconsistently applied across different patient demographics and that audit and enforcement mechanisms are not yet closing the gap.
Chronic Pain and Long-term Health Outcomes
For patients living with chronic conditions, the pain gap contributes to a lower overall quality of life, reduced ability to work and increased disability. These disparities persist even when controlling for socioeconomic status, insurance coverage and clinical severity, suggesting that the drivers are sociocultural and structural rather than biological.
In patients with chronic lower back pain, black adults report more severe and disruptive pain than white adults. Dr John Licciardone stated: “These findings are striking because they highlight that racial pain disparities are impacted by sociocultural factors and are not simply the result of genetic or biological differences.” In practice, that can translate into shorter consultations, fewer referrals to specialist pain services and more frequent questioning of symptom severity when the patient is from a minority ethnic group.
The gap is equally pronounced in the treatment of Parkinson’s disease, where access to analgesia is starkly divided by ethnicity:
- General Pain Relief: Received by 83% of white patients, compared to 48% of black patients and 43% of Asian patients.
- Opioid Prescription: 43% of white patients received opioids, while only 4% of black and Asian patients received the same treatment.
Such figures point to more than individual prejudice: they highlight how pain is assessed, coded and prioritised within the wider system of chronic disease management. Commissioners and health planners who benchmark services primarily on survival and hospital utilisation risk missing a quieter but pervasive pattern of inequitable symptom control.
Palliative Care, Human Rights and End-of-Life Dignity
The final stage of the pain gap occurs in cancer and palliative care, where the principles of dignity and comfort are supposed to be non-negotiable. In England, where cancer accounts for nearly 28% of deaths, the delivery of end-of-life analgesia remains unequal. Patients from black, South Asian, and mixed backgrounds receive fewer opioid prescriptions and lower doses of medication during their final three months of life, despite similar burdens of pain.
Jonathan Koffman, a professor of palliative care, emphasized the human rights implications of this disparity: “Adequate pain relief is a human right. Up to 90% of cancer patients experience pain as they near the end of life. Effective treatment matters not just for comfort, but for dignity, quality of life and even survival. Opioid medicines have proved to be highly effective in managing pain.” His framing reflects a growing view in international health law that access to essential pain medication is part of the core obligations of states under the right to health.
The lack of effective community-based pain management for minority ethnic patients is reflected in their healthcare utilization patterns. These patients are more likely to experience multiple emergency department visits and hospital admissions in their final months, indicating that their pain is frequently undertreated until it reaches a crisis point, necessitating acute institutional intervention. For governments and regulators, such patterns raise questions not only about equality legislation and public-sector duty but also about whether funding formulas, quality indicators and inspection regimes are sufficiently sensitive to racial disparities in pain control.
Closing the ethnicity pain gap will ultimately require more than better bedside manners. It demands that health authorities embed equity in clinical guidelines, link regulatory oversight to measurable pain outcomes across ethnic groups, and ensure that the right to relief from unnecessary suffering is upheld in practice, not just promised on paper.
